Screening for PS1 mutations in a referral-based series of AD cases: 21 Novel mutations

Neurology

Volumn 57, Issue 4, 2001, Pages 621-625

  Rogaeva, Ekaterina A ^a,i   Fafel, K C ^b   Song, Y Q ^a   Medeiros, H ^a   Sato, C ^a   Liang, Y ^a   Richard, E ^a   Rogaev, E I ^a,e   Frommelt, P ^c   Sadovnick, A D ^d   Meschino, W ^f   Rockwood, K ^g   Boss, M A ^b   Mayeux, R ^h   St George Hyslop, P ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b ATHENA DIAGNOSTICS INC   (United States)

^c Asklepios Klinik Schaufling   (Germany)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^f NORTH YORK GENERAL HOSPITAL   (Canada)

^g DALHOUSIE UNIVERSITY   (Canada)

^h Columbia University Irving Medical Center   (United States)

ⁱ Tanz Neuroscience Building ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PRESENILIN 1;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DIAGNOSTIC TEST; FAMILY HISTORY; FEMALE; GENE MUTATION; GENE SEQUENCE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN READING FRAME; PATIENT REFERRAL; PRIORITY JOURNAL; SCREENING;

EID: 0035964209     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.4.621     Document Type: Article

References (26)

1. Molecular genetics of Alzheimer disease
2. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
3. Presenilin mutations in Alzheimer's disease
4. Molecular genetics of Alzheimer's disease: The role of beta-amyloid and the presenilins
5. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease
6. The Glu318Gly substitution in presenilin 1 is not causally related to Alzheimer disease
7. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease
8. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression
9. Presenilin polymorphisms in Alzheimer's disease
10. No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease
11. Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease
12. Early-onset familial Alzheimer's disease and spastic paraparesis associated with a novel insertional mutation of the presenilin 1 gene
13. A pedigree with a novel presenilin 1 mutation at a residue that is not conserved in presenilin 2
14. Identification of a novel mutation (Leu282Arg) of the human presenilin 1 gene in Alzheimer's disease
15. Evidence for phosphorylation and oligomeric assembly of presenilin
16. Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C
17. The nonconserved hydrophilic loop domain of presenilin (PS) is not required for PS endoproteolysis or enhanced abeta 42 production mediated by familial early onset Alzheimer's disease-linked PS variants
18. The biological and pathological function of the presenilin-1 exon 9 mutation is independent of its defect to undergo proteolytic processing
19. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1
20. Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations
21. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype
22. Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum
23. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
24. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease